influenza
Conditions
Interventions
Test group:Xiao'er Feire Kechuan Granules
Sponsors
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
1 Years to 14 Years
Inclusion criteria
Inclusion criteria: Only those who meet all the following criteria can be selected (1) Comply with the clinical diagnosis of influenza in the influenza diagnosis and treatment plan (2020 version) in 2020; (2) Those who comply with traditional Chinese medicine syndrome differentiation and are classified as heat toxin attacking lung syndrome; (3) Age 1-14 years old; (4) Disease duration = 72 hours; (5) Agree to cooperate with medication and undergo evaluation according to the requirements of the experimental protocol; (6) Must obtain the informed consent of the legal guardian of the subject and voluntarily sign the informed consent form; When the subject is able to make a decision to participate in a clinical trial, they must also obtain their own consent.
Exclusion criteria
Exclusion criteria: Those who meet any of the following criteria need to be excluded (1) Have used drugs that may affect the evaluation of the trial efficacy within the past week (such as antipyretic and analgesic drugs, antibiotics, H1 receptor blockers, vasoconstrictors, etc.); (2) Patients treated with systemic steroid or other immunosuppressive agents; (3) Individuals with a history of liver disease; (4) Those who have already discovered shadows or signs of infection in the lungs; (5) Individuals with severe liver, kidney, heart, vascular, neurological, endocrine, immune function disorders, or cancer; (6) Those who are clearly allergic to the experimental drug or its formulation components, or have allergic constitution; (7) Those who have participated in clinical trials within 3 months; (8) White blood cell count is too high (>50 * 109/L) or too low (<4 * 109/L); (9) Researchers believe that individuals should not be included.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical total effective rate;Changes in main symptom scores; | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary symptom score changes;Changes in tongue pulse integral;Usage of symptomatic treatment drugs; | — |
Countries
China
Contacts
Public ContactXuefeng Wang
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Outcome results
None listed